An economic analysis of SSRI length of therapy.
Regan
Tim
T
Applied Health Outcomes, USA.
Bramley
Thomas
T
D003362:Cost-Benefit Analysis; D003863:Depression / Q000188:drug therapy*; D017723:Drug Utilization Review; D017048:Health Care Costs / Q000706:statistics & numerical data; D006801:Humans; D008329:Managed Care Programs / Q000706:statistics & numerical data; D010349:Patient Compliance; D017367:Selective Serotonin Reuptake Inhibitors / Q000191:economics* / Q000627:therapeutic use*; D013221:State Health Plans / Q000706:statistics & numerical data; D013714:Tennessee; D013997:Time Factors
D017367:Selective Serotonin Reuptake Inhibitors